跳至主要内容
临床试验/NCT04328675
NCT04328675Unknown不适用

Registration Study of Natural History and Clinical Characteristics of Amyotrophic Lateral Sclerosis (ALS) in Mainland China

Peking University Third Hospital1 个研究点 分布在 1 个国家目标入组 4,752 人开始时间: 2020年3月20日最近更新:
适应症

试验速览

阶段
不适用
入组人数
4,752
试验地点
1
主要终点
Effective Survival

研究概览

简要总结

A multi-center registration study of natural history and clinical characteristics of ALS in mainland China

详细描述

Amyotrophic lateral sclerosis (ALS) is a rapidly progressive neurodegenerative disease of unknown etiology that is currently incurable. This study is a national multi-center registration study. The study collects general information of ALS patients including medical history, disease characteristics, clinical treatment data, and patient information for different visits in different centers. The aim of the study is: a) describe the distribution of ALS in mainland China(explore the differences in the number of ALS at different times, different regions, and different populations) and further find the reasons that affect the distribution of ALS, b) study the development of ALS in mainland China and the corresponding changes in the characteristics of the disease, c) explore factors that influence the prognosis of ALS.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Clinical diagnosis of laboratory-supported probable, probable, or definite ALS according to EI Escorial diagnostic criteria
  • Age: 18-70 years

排除标准

  • Refuse to cooperate or reject the informed consent

结局指标

主要结局

Effective Survival

时间窗: through study completion, an average of 3 month

The length of time from the date of diagnosis to patient death or tracheotomy or ventilator-assisted breathing.

次要结局

  • Rate of BMI decline(through study completion, an average of 3 month)
  • Rate of disease progression(through study completion, an average of 3 month)
  • Rate of Forced Vital Capacity (FVC)(through study completion, an average of 3 month)
  • Overall Survival(through study completion, an average of 3 month)
  • Rate of Weight decline(through study completion, an average of 3 month)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验